Have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food
The FDA has reported adverse-event concerns involving compounded semaglutide and tirzepatide, including dosing errors, gastrointestinal symptoms, and events that required medical attention
New obesity drugs, beyond Ozempic/Wegovy, are working on the key drawbacks of GLP-1 namely tolerability
It usually appears in the first three to five days and tends to be mild to moderate in intensity, nothing like the nausea associated with starting semaglutide or tirzepatide , but uncomfortable enough to notice
The FDA is offering a 60- to 90-day grace period before compounders have to stop manufacturing tirzepatide to minimise disruption for patients
Products are stored in industrial-grade freezers prior to shipment to maintain stability and purity